Ignite Creation Date:
2024-05-05 @ 12:05 PM
Last Modification Date:
2024-10-26 @ 9:20 AM
Study NCT ID:
NCT00235755
Status:
COMPLETED
Last Update Posted:
2017-04-21
First Post:
2005-10-06
Brief Title:
Retigabine Efficacy and Safety Trial for Partial Onset Refractory Seizures in Epilepsy
Sponsor:
GlaxoSmithKline
Organization:
GlaxoSmithKline
Key Dates - Follows AllAPIJSON File Order
Start Date:
2005-12
Start Date Type:
None
Primary Completion Date:
2008-04
Primary Completion Date Type:
ACTUAL
Completion Date:
2008-04
Completion Date Type:
ACTUAL
First Submit Date:
2005-10-06
First Submit QC Date:
October 6 2005
Study First Post Date:
2005-10-10
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2011-11-06
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-03-23
Last Update Post Date:
2017-04-21
Last Update Post Date Type:
ACTUAL